The study explores the previously unexamined link between exogenous insulin treatment for diabetes mellitus and its potential to alter the risk of osteoarthritis (OA) using Mendelian randomization (MR) to investigate a possible causal relationship. The gene discussed is INS; the disease is diabetes mellitus.